Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
More than 20 years after the identification of the hepatitis C virus (HCV) as a novel human pathogen, the only approved treatment remains a combination of pegylated interferon-α and ribavirin. This rather non-specific therapy is associated with severe side effects and by far not everyone benefits fr...
| Główni autorzy: | , , |
|---|---|
| Format: | Artykuł |
| Język: | English |
| Wydane: |
MDPI AG
2010-09-01
|
| Seria: | Viruses |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.mdpi.com/1999-4915/2/10/2169/ |